Multi-omic Approach to Study HDR Brachytherapy for Favorable Risk and Low Tier Intermediate Risk Prostate Cancer

RecruitingOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

February 1, 2024

Primary Completion Date

March 1, 2028

Study Completion Date

February 1, 2038

Conditions
Localized Prostate Carcinoma
Interventions
RADIATION

High dose rate prostate brachytherapy

Temporary implantation of radioactive material into the prostate in the form of a stepping source of Iridium 192 that travels through 16-18 needles or catheters strategically placed through the prostate.

Trial Locations (1)

V1Y 5L3

RECRUITING

British Columbia Cancer Center for the Southern Interior, Kelowna

All Listed Sponsors
collaborator

BC Cancer Foundation

OTHER

collaborator

University of British Columbia

OTHER

collaborator

Vancouver Prostate Centre

OTHER

lead

British Columbia Cancer Agency

OTHER